Genmab A/S · Copenhagen Denmark (OMX Copenhagen: GEN)
| Bredgade 34 | Phone: +45-7020-2728 |
| Copenhagen | Fax: +45-7020-2729 |
| 1260 | |
| Denmark | 
Map This Company |
Genmab A/S Rankings
Company Description
Genmab analyzes genomes in its lab. The biotech company creates and develops human antibodies to treat such conditions as lymphoma and other cancers, as well as autoimmune and inflammatory diseases. It has assembled a portfolio of products under its HuMax brand that are in different stages of development, ranging from pre-clinical to late-stage trials. In addition to developing its HuMax products, Genmab is working to create products for conditions such as infectious diseases and vascular conditions. The company has licensing and development partnerships with several international pharmaceutical and biotech companies including
Genmab A/S Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OMX Copenhagen: GEN Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 189 |
Executives
13 executives listed for Genmab A/S's Copenhagen, Denmark location.
| Chairman | Michael Widmer | |
|---|---|---|
| Deputy Chairman | Anders Pedersen | |
| CEO | Jan van de Winkel |